Effect of azone and propylene glycol on penetration of trifluorothymidine through skin and efficacy of different topical formulations against cutaneous herpes simplex virus infections in guinea pigs
- 1 December 1984
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 26 (6) , 819-823
- https://doi.org/10.1128/aac.26.6.819
Abstract
Tropical formulations of 5-trifluoromethyl-2'-deoxyuridine (TFT) containing different concentrations of TFT, Azone (Nelson Research and Development, Irvine, Calif.), and propylene glycol were evaluated for their potential efficacy in the treatment of cutaneous herpes simplex virus infections by in vitro studies of TFT penetration through skin and in vivo studies of therapeutic activity against herpes simplex virus type 1 infections in the dorsal cutaneous guinea pig model. Azone dramatically increased TFT penetration through human and guinea pig skin. Unexpectedly, high concentrations of propylene glycol were also associated with increased penetration. Studies in the guinea pig model revealed increased efficacy with Azone-propylene glycol-containing formulations, consistent with the in vitro drug diffusion results. A formulation containing 1% TFT, 5% Azone, and 80% propylene glycol decreased lesion area, in comparison to the drug vehicle control, more effectively than 5% acyclovir in polyethylene glycol (reduction of 70 versus 46%, P = 0.03). These studies demonstrate the value of penetration-enhancing agents and the need for careful preclinical evaluations in the development of topical antiviral agents.This publication has 12 references indexed in Scilit:
- Early, patient-initiated treatment of herpes labialis with topical 10% acyclovirAntimicrobial Agents and Chemotherapy, 1984
- Penetration of guinea pig skin by acyclovir in different vehicles and correlation with the efficacy of topical therapy of experimental cutaneous herpes simplex virus infectionAntimicrobial Agents and Chemotherapy, 1984
- Combined chemotherapy of cutaneous herpes simplex infection of the guinea pigJournal of Medical Virology, 1983
- TrifluridineDrugs, 1982
- The Sensitivity of Acyclovir-Resistant Mutants of Herpes Simplex Virus to Other Antiviral DrugsThe Journal of Infectious Diseases, 1981
- Comparative Efficacy of Antiherpes Drugs against Different Strains of Herpes Simplex VirusThe Journal of Infectious Diseases, 1980
- HEp-2 Cell- and Herpes Simplex Virus Type 1- Induced Deoxythymidine Kinases: Inhibition by Derivatives of 5-Trifluoromethyl-2′-DeoxyuridineAntimicrobial Agents and Chemotherapy, 1978
- Experimental Herpes Simplex Virus Type 1 Encephalitis: Treatment with 5-Trifluoromethyl-2′-DeoxyuridineAntimicrobial Agents and Chemotherapy, 1977
- Guinea Pig Model for Cutaneous Herpes Simplex Virus InfectionJournal of Investigative Dermatology, 1974
- Therapeutic Antiviral Action of 5-Trifluoromethyl-2′-deoxyuridine in Herpes Simplex KeratitisScience, 1964